Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SOLASTA Bio
Glasgow, Scotland, United Kingdomsolastabio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
SOLASTA Bio has developed the world’s first nature-inspired peptide technology platform for creating highly specific, environmentally friendly bioinsecticides. Their lead products disrupt key neuropeptide pathways in target pests while sparing pollinators and other non-target species. Field trials across Europe, the UK, and US have shown efficacy at least equal to commercial standards. The company has secured strong patent protection and favorable regulatory status from the US EPA for its lead peptides, which should accelerate time-to-market compared to traditional synthetic pesticides. Commercial launch targeted for as early as 2027.
- Therapeutic areas
- Other
- Modalities
- PeptidesProtein-based biopesticides (small protein/peptide-based agents)Biologic
- Industry
- Agriculture & AgTech
02
Partnerships
No formal commercial partnerships disclosed yet; investors include major agri-business strategics such as FMC Ventures (FMC Corporation) and Corteva Catalyst/Corteva Inc., which may indicate future partnership potential.
Beyond the preview
Go deeper on SOLASTA Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SOLASTA Bio.